Citigroup »

An2 Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2024-03-31 $230k 71k 3.25
2023-12-31 $3.3M 161k 20.49
2023-09-30 $2.6M 159k 16.08
2023-03-31 $1.3M 135k 9.87
2022-12-31 $1.3M 135k 9.53
2022-09-30 $2.3M 135k 17.38